Cite
Seeley TW, Sternlicht MD, Klaus SJ, et al. Induction of erythropoiesis by hypoxia-inducible factor prolyl hydroxylase inhibitors without promotion of tumor initiation, progression, or metastasis in a VEGF-sensitive model of spontaneous breast cancer. Hypoxia (Auckl). 2017;5:1-9doi: 10.2147/HP.S130526.
Seeley, T. W., Sternlicht, M. D., Klaus, S. J., Neff, T. B., & Liu, D. Y. (2017). Induction of erythropoiesis by hypoxia-inducible factor prolyl hydroxylase inhibitors without promotion of tumor initiation, progression, or metastasis in a VEGF-sensitive model of spontaneous breast cancer. Hypoxia (Auckland, N.Z.), 51-9. https://doi.org/10.2147/HP.S130526
Seeley, Todd W, et al. "Induction of erythropoiesis by hypoxia-inducible factor prolyl hydroxylase inhibitors without promotion of tumor initiation, progression, or metastasis in a VEGF-sensitive model of spontaneous breast cancer." Hypoxia (Auckland, N.Z.) vol. 5 (2017): 1-9. doi: https://doi.org/10.2147/HP.S130526
Seeley TW, Sternlicht MD, Klaus SJ, Neff TB, Liu DY. Induction of erythropoiesis by hypoxia-inducible factor prolyl hydroxylase inhibitors without promotion of tumor initiation, progression, or metastasis in a VEGF-sensitive model of spontaneous breast cancer. Hypoxia (Auckl). 2017 Mar 10;5:1-9. doi: 10.2147/HP.S130526. eCollection 2017. PMID: 28331872; PMCID: PMC5354531.
Copy
Download .nbib